# Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion

> **NCT06146309** · NA · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 60 (actual)

## Conditions studied

- Branch Retinal Vein Occlusion

## Interventions

- **DRUG:** aflibercept (2mg/0.05ml)

## Key facts

- **NCT ID:** NCT06146309
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2022-07-20
- **Final completion:** 2022-08-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146309, "Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06146309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*